is a helpful next read
doi: 10.3389/fphar.2025.1610512 Received 12 April 2025 Accepted 15 May 2025 Published 30 May 2025 Volume 16 - 2025 Edited by Karuna Rasineni, University of Nebraska Medical Center, United States Reviewed by Asher Rajkumar Rajan, University of Nebraska Medical Center, United States Akash Batta, Dayanand Medical College & Hospital, India Updates Copyright 2025 Li, Huang, Wang, Huang, Luo and Huang
Medical-grade injectable fat reduction (where appropriate) A clinician may discuss established injectable options when clinically indicated, with a full consent process and careful technique
Moreover, differences in outcome reporting, such as the use of absolute versus relative changes, or inconsistent definitions of endpoints like visceral adiposity or insulin resistance, further limited the ability to standardize data extraction and synthesis